Annotated Medicine and Device Lists

Sodium chloride

Bag 0.9% in 50ml Bag 0.9% in 100ml Injectable solution 0.9% (9 mg/mL) - Bag 100 mL. Injectable solution 0.9% isotonic (equivalent to Na+ 154 mmol/L, Cl- 154 mmol/L) Injectable solution 0.9% (9 mg/mL) -50 mL Injectable solution 0.9% (9 mg/mL)-10 mL Injection 0.9% in 250ml (glass bottle) Injection 23.4% 30 ml Injection 0.9 % in 2500ml Injection 17.7 % Injection 23.4 % in 20ml Intravenous administration 0.9% 1 litre N/A 0.45% N/A 0.9% N/A 3% N/A 5% N/A Parenteral formulation 0.9% (100 mL) Parenteral formulation 0.9% (1 L) Parenteral formulation 0.9% (20 mL) Parenteral formulation 0.9% (5 mL) Parenteral formulation 0.9% (250 mL) Parenteral formulation 0.9% (500 mL) Parenteral formulation 20% (20 mL) Parenteral formulation 20% (30mL) Parenteral formulation 0.9% (1000mL) Parenteral formulation 0.45% (1L) Parenteral formulation 0.45% (500mL) Parenteral formulation 0.45% Parenteral solution 0.9% in 500-mL bottle Parenteral solution 0.9% in 250-mL plastic bag Parenteral solution 0.9% 1000-mL bottle Solution 0.9% 500 ml Solution 3% x 500 ml Solution 1 mEq/mL Solution 0.9% 250 ml Solution (eye drops) 0.9%, 10mL Solution (eye drops) 0.9%, 0.5 mL x 20 (minims) Solution for inhalation 0.9% in 3ml vial Solution for injection 9% / 50 ml

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	26.2. Parenteral	No observations
Belize. National Drug Formulary	26.02 Parenteral	No observations

This medicine is present in:

List	Section	Observation
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations

This medicine is present in:

List	Section	Observation
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	13.11 Skin Disinfecting and Cleaning Agents	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Balance Electrolyte Fluids & Water	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.03 IV Nutrition	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Belize. National Drug Formulary	26.02 Parenteral	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Balance Electrolyte Fluids & Water	No observations

This medicine is present in:

List	Section	Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	10.2.2 Intravenous Infusions	No observations

This medicine is present in:

List	Section	Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	10.2.2 Intravenous Infusions	No observations
Haiti. National List of Essential Medicines	23. Solutions for Peritoneal Dialysis	No observations
Haiti. National List of Essential Medicines	26.02. Parenteral route	No observations

This medicine is present in:

List	Section	Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	10.2.2 Intravenous Infusions	No observations

This medicine is present in:

List	Section	Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015	10.2.2 Intravenous Infusions	No observations

This medicine is present in:

List	Section	Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016	Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC	Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS (INCLUYE SOLUCIONES PARENTERALES DE PEQUEÑO Y GRAN VOLUMEN) SALVO: FORMAS FARMACÉUTICAS DE ADMINISTRACIÓN NASAL O FORMAS FARMACÉUTICAS DE ADMINISTRACIÓN RECTAL
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018	12.08. FARMACOS DE INSTILACION Y LAVADO DE VEJIGA	No observations
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018	13.02. FARMACOS DE ACCION RINOOROFARINGEA	No observations
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018	19.02. SOLUCIONES PARENTERALES	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019	43. Electrolitos y soluciones parenterales	Others observations: Solución isotónica inyectable. Bolsa.
Suriname. NGK-C-011	27.2 Parenteral Agents	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	07.04.04 Drugs for Urological Surgery	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Guyana. Essential Medicines List. 2020-2021	26.02. Parenteral Solutions	No observations
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021	40:12 Replacement Solutions/ agents	No observations
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021	40:12 Replacement Solutions/ agents	No observations
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Guyana. Essential Medicines List. 2020-2021	26.02. Parenteral Solutions	No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021	40:12 Replacement Solutions/ agents	No observations
Suriname. NGK-C-011	27.2 Parenteral Agents	No observations
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Peru	27.2 Parenteral	No observations
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Suriname. NGK-C-011	27.2 Parenteral Agents	No observations

This medicine is present in:

List	Section	Observation
Suriname. NGK-C-011	27.2 Parenteral Agents	No observations

This medicine is present in:

List	Section	Observation
Guyana. Essential Medicines List. 2020-2021	26.02. Parenteral Solutions	No observations
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations
Bahamas. Drug Formulary	12. 02 Parenteral Electrolytes	No observations

This medicine is present in:

List	Section	Observation
Guyana. Essential Medicines List. 2020-2021	26.02. Parenteral Solutions	No observations
Barbados. Barbados National Drug Formulary (BNDF)	40.12 Replacement Therapy	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations

This medicine is present in:

List	Section	Observation
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021	40:12 Replacement Solutions/ agents	No observations
Haiti. National List of Essential Medicines	26.02. Parenteral route	No observations

This medicine is present in:

List	Section	Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.	CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.	No observations

This medicine is present in:

List	Section	Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.	CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.	No observations

This medicine is present in:

List	Section	Observation
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.	CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Balance Electrolyte Fluids & Water	No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019	43. Electrolitos y soluciones parenterales	Others observations: Solución isotónica inyectable. Bolsa.
Cayman Islands Health Services Authority Pharmacy Drug Formulary	13.11 Skin Disinfecting and Cleaning Agents	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	07.04.04 Drugs for Urological Surgery	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Balance Electrolyte Fluids & Water	No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary	09.02.02.01 Electrolytes and water	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.	Balance Electrolyte Fluids & Water	Others observations: IV
Costa Rica. Caja Costarricense de Seguro Social. 2019	43. Electrolitos y soluciones parenterales	Others observations: Solución isotónica inyectable. Bolsa.

This medicine is present in:

List	Section	Observation
Cayman Islands Health Services Authority Pharmacy Drug Formulary	11.08.01 Tear Deficiency, Ocular Lubricants and Astringents	No observations

This medicine is present in:

List	Section	Observation
Cayman Islands Health Services Authority Pharmacy Drug Formulary	11.08.01 Tear Deficiency, Ocular Lubricants and Astringents	No observations

This medicine is present in:

List	Section	Observation
Bahamas. Drug Formulary	03. RESPIRATORY DRUGS	No observations

This medicine is present in:

List	Section	Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019	43. Electrolitos y soluciones parenterales	Others observations: Solución isotónica inyectable. Bolsa libre de PVC o envase de vidrio.

Information Resources: Sodium chloride

Should children with dengue fever be treated with intravenous colloids compared to crystalloids?
Dengue Fever.